T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Edgewise Therapeutics
EWTX
$4.73B
| $834K | ﹤0.01% |
51,386
+704
| +1% | +$9.98K |
|
|
BRSP
2127
BrightSpire Capital
BRSP
$628M
| $833K | ﹤0.01% |
153,270
+2,606
| +2% | +$14.2K |
|
|
CTO
2128
CTO Realty Growth
CTO
$819M
| $832K | ﹤0.01% |
50,989
+9,797
| +24% | +$165K |
|
2129
Ingles Markets
IMKTA
$1.66B
| $829K | ﹤0.01% |
11,905
+693
| +6% | +$46.2K |
|
2130
DXP Enterprises
DXPE
$3.04B
| $826K | ﹤0.01% |
6,937
+439
| +7% | +$49.1K |
|
|
PONY
2131
Pony AI Inc
PONY
$3.62B
| $825K | ﹤0.01% |
36,661
-74,899
| -67% | -$1.14M |
|
2132
Shenandoah Telecom
SHEN
$721M
| $823K | ﹤0.01% |
61,306
+1,373
| +2% | +$18.9K |
|
|
PPTA
2133
Perpetua Resources
PPTA
$3.16B
| $819K | ﹤0.01% |
40,438
+17,418
| +76% | +$294K |
|
|
CDTX
2134
DELISTED
Cidara Therapeutics
CDTX
| $817K | ﹤0.01% |
8,524
+120
| +1% | +$7.66K |
|
2135
Nu Skin
NUS
$236M
| $815K | ﹤0.01% |
66,816
+2,810
| +4% | +$29.5K |
|
2136
DHT Holdings
DHT
$3.01B
| $814K | ﹤0.01% |
68,042
+4,517
| +7% | +$52.4K |
|
2137
AMN Healthcare
AMN
$1.34B
| $813K | ﹤0.01% |
41,990
+4,010
| +11% | +$78.3K |
|
2138
Ceco Environmental
CECO
$4.44B
| $813K | ﹤0.01% |
15,877
+1,095
| +7% | +$46.3K |
|
2139
Mineralys Therapeutics
MLYS
$2.39B
| $811K | ﹤0.01% |
21,383
+1,815
| +9% | +$39.3K |
|
2140
Hackett Group
HCKT
$278M
| $810K | ﹤0.01% |
42,604
+5,657
| +15% | +$124K |
|
2141
Winmark
WINA
$1.26B
| $806K | ﹤0.01% |
1,618
+153
| +10% | +$65.7K |
|
2142
Novartis
NVS
$290B
| $802K | ﹤0.01% |
6,240
-300
| -5% | -$36.6K |
|
2143
Tandem Diabetes Care
TNDM
$1.63B
| $799K | ﹤0.01% |
65,803
+6,600
| +11% | +$89.3K |
|
2144
Select Water Solutions
WTTR
$2.73B
| $798K | ﹤0.01% |
74,648
+3,461
| +5% | +$31.6K |
|
2145
Centuri Holdings
CTRI
$2.4B
| $798K | ﹤0.01% |
+37,663
| New | +$799K |
|
|
AMWD
2146
DELISTED
American Woodmark
AMWD
| $797K | ﹤0.01% |
11,935
+388
| +3% | +$23.8K |
|
2147
Vitesse Energy
VTS
$685M
| $796K | ﹤0.01% |
34,253
+752
| +2% | +$18.5K |
|
2148
Western New England Bancorp
WNEB
$282M
| $793K | ﹤0.01% |
65,982
+4,200
| +7% | +$47.9K |
|
2149
Keros Therapeutics
KROS
$222M
| $791K | ﹤0.01% |
49,981
+1,566
| +3% | +$23.1K |
|
2150
Blackstone Secured Lending
BXSL
$5.69B
| $789K | ﹤0.01% |
30,262
-35,109
| -54% | -$1.05M |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.